Sign in
4

Changes in Ownership

Spero Therapeutics, Inc. Filed Acc 0000899243-22-004586

Chief Legal Officer acquired 38,014 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
JOSEPH TAMARA L Chief Legal Officer 2022-02-01 Grant or award +38,014 62,081 D
Derivatives
JOSEPH TAMARA L Chief Legal Officer 2022-02-01 Grant or award · Stock Option (Right to Buy) +53,190 53,190 D
Loading xslF345X03/doc4.xml…